The Latest Breaking News from ZTS

Despite Zoetis’s underperformance relative to the Dow Jones Industrials Average over the past year, Wall Street analysts remain optimistic about the stock’s prospects.

The pet care industry is expected to witness immense growth owing to a surge in pet adoptions, veterinary innovations, and rising disposable income. Thus, one could scoop up shares of fundamentally solid pet-care stocks with tail-wagging potential, like Zoetis (ZTS), Chewy (CHWY), and PetIQ (PETQ). Read more….

Zoetis (ZTS) continues to showcase its solid market position and commitment to innovation across its diverse portfolio, introducing advanced products that meet the evolving needs of animal health. Given its robust fundamentals and industry leadership, let’s find out if ZTS is a solid choice for those looking to invest in…

Despite Zoetis lagging behind the broader market over the past year, analysts still remain strongly bullish on the stock’s prospects.

As Zoetis is all set to announce its second-quarter earnings next month, analysts project a single-digit improvement in its bottom line.

The pet care industry’s robust expansion is driven by rising disposable income, adoption of e-commerce platforms, and rising pet ownership. Therefore, investors could consider watching fundamentally sound pet care stocks, Zoetis (ZTS), IDEXX Laboratories (IDXX), and Chewy (CHWY). Keep reading.

Amid a broader market rotation out of Big Tech stocks, investors can consider these three top-rated healthcare stocks with double-digit upside potential.

The pharmaceutical industry’s long-term growth is fueled by a surge in demand for personalized medicine, favorable R&D initiatives, and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid pharma stocks Zoetis (ZTS), Viatris (VTRS), and Bristol-Myers Squibb (BMY) poised for blockbuster return potential. Keep reading….

Despite Zoetis significantly trailing behind the Nasdaq Composite over the past three months, analysts seem extremely bullish on the stock’s prospects due to its robust product pipeline and global reach.

Amid growing demand for specialty drugs and increasing adoption of emerging technology in pharmaceutical manufacturing, the pharma industry is witnessing steady expansion. Therefore, quality pharmaceutical stocks Zoetis (ZTS), Viatris (VTRS), MEI Pharma (MEIP), and Amphastar Pharmaceuticals (AMPH) could be ideal additions to your watchlist. Keep reading….

The pharma sector is poised for strong growth thanks to rising demand for personalized treatments, an aging population, advancements in pharma technology, and innovative approaches to drug discovery and manufacturing. Hence, investors could consider buying quality pharmaceutical stocks such as Zoetis (ZTS), Rigel Pharmaceuticals (RIGL), and Kamada (KMDA) with May…